Carnitina en la bioenergtica del msculo humano: puede la suplementacin con carnitina mejorar el ejercicio fsico
You came to lose weight, but you also want to keep your strength and energy
Trial participation is not the same as receiving a routine prescription
Dokken BB, La Bonte LR, Davis-Gorman G, Teachey MK, Seaver N, McDonagh PF: Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents
If your RA is active, you still need appropriate DMARD or biologic therapy first
Investments in biomarker discovery, personalized therapies, and innovative trial frameworks should be matched by equitable health system reforms and coordinated policy alignment